Proliferation of Ewing sarcoma cell lines is suppressed by the receptor tyrosine kinase inhibitors gefitinib and vandetanib

BACKGROUND: Tyrosine kinase inhibitors (TKIs) have gained much attention in recent years as targeted agents for the treatment of a wide range of human cancers. We have investigated the effect of the TKIs gefitinib and vandetanib on tumor cell lines derived from Ewing sarcoma, a highly malignant tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersson, Mattias K, Åman, Pierre
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2235833/
https://www.ncbi.nlm.nih.gov/pubmed/18177496
http://dx.doi.org/10.1186/1475-2867-8-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2235833/
https://www.ncbi.nlm.nih.gov/pubmed/18177496
http://dx.doi.org/10.1186/1475-2867-8-1

Ejemplares similares